[Skip to Content]
[Skip to Content Landing]
Article
April 1994

Should We Recommend Vitreous Surgery for Patients With Choroidal Neovascularization?

Author Affiliations

Baltimore, Md

Arch Ophthalmol. 1994;112(4):459-461. doi:10.1001/archopht.1994.01090160035017

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

THE SEQUELAE of choroidal neovascularization (CNV) are important causes of visual morbidity. Age-related macular degeneration (AMD) is the leading cause of visual loss in older Americans. Approximately 90% of blindness secondary to AMD is related to the neovascular type of AMD. Neovascular complications of the ocular histoplasmosis syndrome (OHS) can be an important cause of blindness in younger Americans, especially if untreated.

Laser treatment, as demonstrated in clinical trials by the Macular Photocoagulation Study (MPS) Group, shows a very strong treatment benefit with respect to decreasing the risk of severe visual acuity loss in patients with extrafoveal or juxtafoveal CNV complicating AMD1,2 or OHS,3,4 as well as in patients with new (no prior treatment) subfoveal or recurrent subfoveal CNV complicating AMD.5,6 Patients can expect to preserve good visual acuity (20/40 or better) following laser treatment in more than 85% of extrafoveal cases secondary to OHS. However, virtually

References
1.
Macular Photocoagulation Study Group.  Argon laser photocoagulation for neovascular maculopathy: five-year results from randomized clinical trials . Arch Ophthalmol . 1991;109:1109-1114.Article
2.
Macular Photocoagulation Study Group.  Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results of a randomized clinical trial . Arch Ophthalmol . 1990;108:816-824.Article
3.
Macular Photocoagulation Study Group.  Argon laser photocoagulation for ocular histoplasmosis: results of a randomized clinical trial . Arch Ophthalmol . 1983;101:1347-1357.Article
4.
Macular Photocoagulation Study Group.  Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis: results of a randomized clinical trial . Arch Ophthalmol . 1987;105:1499-1507.Article
5.
Macular Photocoagulation Study Group.  Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial . Arch Ophthalmol . 1991;109:1219-1230.
6.
Macular Photocoagulation Study Group.  Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial . Arch Ophthalmol . 1991;109:1232-1241.Article
7.
Fine SL, Wood WJ, Singerman LJ, et al.  Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial . Arch Ophthalmol . 1993;111:19-20.Article
8.
de Juan E, Machemer R.  Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration . Am J Ophthalmol . 1987;105:25-29.
9.
Lambert HM, Capone A, Aaberg TM, Sternberg P, Mandell BA, Lopez PF.  Surgical excision of subfoveal neovascular membranes in age-related macular degeneration . Am J Ophthalmol . 1991;113:257-262.
10.
Thomas MA, Grand, G, Williams DF, Lee CM, Pesin SR, Lowe MA.  Surgical management of subfoveal choroidal neovascularization . Ophthalmology . 1992;99:952-968.Article
11.
Berger AS, Kaplan HJ.  Clinical experience with the surgical removal of subfoveal neovascular membranes: short-term postoperative results . Ophthalmology . 1992;99:969-976.Article
12.
Grossniklaus HE, Martinez JA, Brown VB, et al.  Immunohistochemical properties of surgically excised neovascular membranes in age-related macular degeneration . Am J Ophthalmol . 1992;114:464-472.
13.
Das A, Puklin JE, Frank RN, Zhang NL.  Ultrastructural and immunocytochemistry of subretinal neovascular membranes in age-related macular degeneration . Ophthalmology . 1992;99:1368-1376.Article
14.
Lopez PF, Lambert HM, Grossniklaus HE, Sternberg P.  Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration . Ophthalmology . 1993;100:415-422.Article
×